I'm not sure yet but Thomas Ichim Ph.D is one of the founders of the company.
Its make better sense if the doctors tackle one cure at a time not multiples. Unless they can because of the waiting period from preclinicals and FDA. IMO
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.